|
?:authorAffiliation
|
-
[\'Department of Medical Oncology, Skåne University Hospital, Lund, Sweden.\', \'Medical Oncology Clinic, Institute Jules Bordet, l\'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.\', \'Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.\', \'Centro de Oncologia, São Paulo, Brazil.\', \'Department of Medicine III, University Hospital, LMU Munich, München, Germany.\', \'Department of Biomedical Sciences, Humanitas University, Milan, Italy.\', \'Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center-IRCCS, Milan, Italy.\', \'Hôpital Saint Louis, Université Paris Diderot, Paris, France.\', \'Department of Medical Oncology, Thoracic Oncology Unit, Fondazione IRCSS, Istituto Nazionale dei Tumori Milano, Milan, Italy.\', \'Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.\', \'Division of Medical Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL.\', \'Gustave Roussy Cancer Center, Villejuif, France.\', \'Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN.\', \'Service d\'oncologie médicale, CHUV, Lausanne, Switzerland.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}